Westergaard J G, Teisner B, Hau J, Grudzinskas J G, Chard T
Obstet Gynecol. 1985 Mar;65(3):316-8.
Maternal blood levels of human placental lactogen and schwangerschaftsprotein 1 were measured in 51 women who delivered a growth-retarded infant. The levels were substantially lower in the 27 women whose infants were clinically dysmature than in the 24 women whose infants were small but of normal appearance. About one-half (44%) the cases of true dysmaturity had abnormal concentrations of human placental lactogen (less than 4 mg/L), whereas none of the small but normal group had values in this zone. It is concluded that biochemical tests of this type reflect dynamic aspects of placental function and not simply the overall size of the fetus and placenta.
对51名分娩出发育迟缓婴儿的女性进行了人胎盘催乳素和妊娠特异性β1糖蛋白的母体血水平检测。在27名婴儿临床不成熟的女性中,这些水平显著低于24名婴儿虽小但外观正常的女性。在真正不成熟的病例中,约一半(44%)人胎盘催乳素浓度异常(低于4mg/L),而在小但正常的组中,没有人的数值处于这一范围。得出的结论是,这类生化检测反映的是胎盘功能的动态方面,而不仅仅是胎儿和胎盘的总体大小。